Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 14Breast Neoplasms 12Multiple Myeloma 8Neoplasm Metastasis 5Pain 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Renal Insufficiency 1Pleural Effusion, Malignant 1Osteoporosis 1Osteonecrosis 1Osteolysis 1Neoplastic Cells, Circulating 1Lung Neoplasms 1Lung Metastases 1Carcinoma, Renal Cell 1Bone Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 1Thoracoscopes 1Talc 1Surveys and Questionnaires 1Sodium Chloride 1Povidone-Iodine 1Pleurodesis 1One-Lung Ventilation 1Fentanyl 1Doxycycline 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pleural Effusion, Malignant × Zoledronic Acid × Clear all
NCT00099541 2009-11-23

Non-small Cell Lung Cancer Registry

Novartis

Phase 4 Completed
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡